Background Pulmonary tuberculosis (PTB) can result in long-term health consequences,
even after successful treatment. We conducted a systematic review and meta-analysis to …

Purpose Impaired health-related quality of life (HRQoL) is associated with poor health
outcomes in chronic obstructive pulmonary disease (COPD). The aim of this study was to …

Background Health-related quality of life (HRQL) is an important patient-reported outcome
measure used to describe the burden of chronic obstructive pulmonary disease (COPD) …

Background Although patients with COPD often have various comorbidities and symptoms,
limited data are available on the contribution of these aspects to health care costs. This …

Purpose Umeclidinium/vilanterol (UMEC/VI) is a novel fixed dose combination of a long-
acting muscarinic receptor antagonist (LAMA) and a long-acting beta 2 receptor antagonist …

There are several different modalities, eg surgery, chemotherapy and radiotherapy, that are
currently used to treat cancer. It is common practice to use a combination of these modalities …

Background COPD is a high prevalence chronic disease that involves large reductions of
health-related quality of life (HRQL) of patients. This study aims to describe the HRQL of …

Objetivo: Sintetizar la información disponible acerca de estudios económicos relacionados
con las exacerbaciones agudas asociadas a la EPOC publicados en España durante los …

Background The cost of chronic obstructive pulmonary disease (COPD) in Spain has been
studied from different perspectives, but parameters such as the patient's phenotype have …

Background: Chronic obstructive pulmonary disease (COPD) is a major cause of mortality
characterized by progressive airflow obstruction and inflammation in the airways, which has …